Reversible atorvastatin-associated external ophthalmoplegia, anti- acetylcholine receptor antibodies, and ataxia

Archives of Ophthalmology

Volumn 118, Issue 3, 2000, Pages 427-428

  Negvesky, Gerald J ^b   Kolsky, Martin P ^a   Laureno, Robert ^b   Yau, Thomas H ^b  

^a Physician's Office Building   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PENICILLAMINE; SIMVASTATIN;

ADULT; ARTICLE; ATAXIA; CASE REPORT; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; EXTERNAL OPHTHALMOPLEGIA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; OPHTHALMOPLEGIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ATAXIA; AUTOANTIBODIES; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MIDDLE AGED; OPHTHALMOPLEGIA; PYRROLES; RECEPTORS, CHOLINERGIC; VISUAL ACUITY;

EID: 0034102202     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Hartman HA, Myers LA, Evans M, et al. The safety evaluation of fluvaslatin, an HMG-CoA reductase inhibitor, in beagle dogs and rhesus monkeys. Fund Appl Toxicol. 1996;29:48-62.
2. Bever CT, Chang HW, Penn AS, et al. Penicillamine-induced myasthenia gravis: effects of penicillamine on acetylcholine receptor. Neurology. 1982;32:1077-1082.
3. Winbrodt ET. Drugs and myasthenia gravis: an update. Arch Intern Med. 1997;157:399-408.
4. Rudski L, Rabinovitch MA, Danoff D. Systemic mimune reactions to HMG-CoA reductase inhibitors. Medicine (Baltimore). 1998;77:378-383.
5. England JD, Walsh JC, Stewart P, Boyd I, Rohan A, Halmagyi GM. Mitochondrial myopathy developing on treatment with the HMG CoA reductase inhibitors: simvastatin and pravastatin. Aust N Z Med. 1995;25:274-275.
6. De Pinieux G, Chariot P, Ammi-Said M, et al. Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum umbiquione and blood lactate/pyruvate ratio. Br J Clin Pharmacol. 1996;42: 333-337.